Clincosm LogoSign in Get a demo

Sickle Cell Disease

Showing NaN - NaN of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Real-world Setting: Preliminary Analysis From Select Sickle Cell

Completed
  • Sickle Cell Disease
    • Birmingham, Alabama
    • +10 more
    Apr 17, 2023

    Sickle Cell Disease Trial in Adana, Mersin (NDec - oral decitabine-tetrahydrouridine, HU - Hydroxyurea, Placebo)

    Recruiting
    • Sickle Cell Disease
    • NDec - oral decitabine-tetrahydrouridine
    • +2 more
    • Oakland, California
    • +39 more
    Jan 24, 2023

    Sickle Cell Disease, Hemoglobinopathies Trial in Canada, United States (EDIT-301)

    Recruiting
    • Sickle Cell Disease
    • Hemoglobinopathies
    • EDIT-301
    • Oakland, California
    • +18 more
    Jan 10, 2023

    Sickle Cell Disease Trial in Italy, United States (OTQ923, HIX763, OTQ923 or HIX763)

    Recruiting
    • Sickle Cell Disease
    • OTQ923
    • Los Angeles, California
    • +4 more
    Jan 9, 2023

    Sickle Cell Disease Trial in Italy, Spain, United States (Crovalimab, Placebo)

    Recruiting
    • Sickle Cell Disease
    • New York, New York
    • +18 more
    Jan 4, 2023

    Sickle Cell Disease Trial in United States (Hematopoietic Stem Cell Transplantation)

    Completed
    Has Results
    • Sickle Cell Disease
    • Hematopoietic Stem Cell Transplantation
    • Birmingham, Alabama
    • +18 more
    Dec 7, 2022

    A Long-term Follow-up Study in Subjects Who Received CTX001

    Enrolling by invitation
    • Beta-Thalassemia
    • +6 more
    • CTX001
    • New York, New York
    • +12 more
    Nov 18, 2022

    Sickle Cell Disease Treated With Ex Vivo Gene Therapy

    Enrolling by invitation
    • Sickle Cell Disease
    • Safety and efficacy assessments
    • Birmingham, Alabama
    • +11 more
    Oct 31, 2022

    Sickle Cell Disease, Genetic Disease, Hematologic Diseases Trial in United States (Electronic Health Record (EHR) Embedded

    Completed
    • Sickle Cell Disease
    • +3 more
    • Electronic Health Record (EHR) Embedded Individualized Pain Plan (IPP)
    • Oakland, California
    • +7 more
    Oct 26, 2022

    Sickle Cell Disease Trial in Worldwide (Etavopivat Tablets, Placebo Tablets)

    Recruiting
    • Sickle Cell Disease
    • Etavopivat Tablets Low dose
    • +3 more
    • Birmingham, Alabama
    • +77 more
    Oct 11, 2022

    Sickle Cell Disease Trial in Worldwide (Voxelotor)

    Active, not recruiting
    • Sickle Cell Disease
    • Little Rock, Arkansas
    • +47 more
    Sep 28, 2022

    Sickle Cell Disease Trial in United States (InCharge Health mobile application, HU Toolbox mobile application)

    Completed
    • Sickle Cell Disease
    • InCharge Health mobile application
    • HU Toolbox mobile application
    • Augusta, Georgia
    • +6 more
    Sep 26, 2022

    Sickle Cell Disease Trial in United States (Busulfan, Fludarabine, r-ATG)

    Active, not recruiting
    • Sickle Cell Disease
    • Oakland, California
    • +34 more
    Sep 21, 2022

    Sickle Cell Disease Trial in France, United Kingdom, United States (Red Blood Cell, Standard of care)

    Recruiting
    • Sickle Cell Disease
    • Red Blood Cell
    • Standard of care
    • Tuscaloosa, Alabama
    • +19 more
    Aug 23, 2022

    Sickle Cell Disease Trial in Worldwide (IMR-687, Placebo)

    Terminated
    • Sickle Cell Disease
    • Birmingham, Alabama
    • +48 more
    May 9, 2022

    Sickle Cell Disease Trial in New York (Plerixafor)

    Recruiting
    • Sickle Cell Disease
    • New York, New York
    • +1 more
    Mar 21, 2022

    Red Blood Cell - IMProving trAnsfusions for Chronically

    Recruiting
    • Sickle Cell Disease
    • +2 more
    • Red Blood Cell (RBC) Transfusion
    • Oakland, California
    • +13 more
    Mar 18, 2022

    Sickle Cell Disease Trial in United States (HABIT Intervention)

    Completed
    • Sickle Cell Disease
    • HABIT Intervention
    • Bronx, New York
    • +3 more
    Mar 7, 2022

    Sickle Cell Disease Trial in United States (Provider-level intervention, Patient-level intervention)

    Active, not recruiting
    • Sickle Cell Disease
    • Provider-level intervention
    • Patient-level intervention
    • Little Rock, Arkansas
    • +14 more
    Feb 24, 2022

    Sickle Cell Disease Trial in United States (bb1111)

    Active, not recruiting
    • Sickle Cell Disease
    • bb1111
    • Birmingham, Alabama
    • +10 more
    Dec 9, 2021

    Sickle Cell Disease, Beta Thalassemia Trial in New York (Busulfan, Fludarabine, Alemtuzumab)

    Active, not recruiting
    • Sickle Cell Disease
    • Beta Thalassemia
    • New York, New York
      Morgan Stanley Children's Hospital, New York-Presbyterian, Colum
    Aug 12, 2021

    Sickle Cell Disease, GVHD Trial in United States (Diphenhydramine, Acetaminophen, Methylprednisolone)

    Active, not recruiting
    • Sickle Cell Disease
    • Graft Versus Host Disease
    • Washington, District of Columbia
    • +6 more
    Aug 4, 2021

    Sickle Cell Pro-Inflammatory Response to Interval Training Study

    Recruiting
    • Sickle Cell Disease
    • Exercise Test (CIIT)
    • Chicago, Illinois
    • +3 more
    Aug 2, 2021

    Sickle Cell Disease, Vaso-occlusive Crisis Trial in New York (Nitrous oxide 50%)

    Terminated
    • Sickle Cell Disease
    • Vaso-occlusive Crisis
    • Nitrous oxide 50%
    • New York, New York
      New York Presbyterian Morgan Stanley Children's Hospital
    Jul 7, 2021

    Sickle Cell Anemia, Sickle Cell Disease, Sickle Cell Disorders Trial in Canada, United States (Rivipansel)

    Terminated
    • Sickle Cell Anemia
    • +4 more
    • Mobile, Alabama
    • +96 more
    Feb 8, 2021